Amedisys Inc (AMED)

AMED (NASDAQ:Health Services) EQUITY
neg -0.27
Today's Range: 58.36 - 59.23 | AMED Avg Daily Volume: 258,000
Last Update: 07/21/17 - 12:42 PM EDT
Volume: 73,519
YTD Performance: 37.81%
Open: $59.06
Previous Close: $58.75
52 Week Range: $31.16 - $54.42
Oustanding Shares: 33,728,276
Market Cap: 1,979,512,518
6-Month Chart
TheStreet Ratings Grade for AMED
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 5 4
Moderate Buy 0 0 0 0
Hold 4 4 5 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 1.89 2.00 2.20
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 42.53
Price Earnings Comparisons:
AMED Sector Avg. S&P 500
42.53 43.20 30.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.82% 11.67% 266.73%
Revenue 12.30 0.10 0.05
Net Income 0.00 -1.40 0.00
EPS 0.00 -1.40 0.00
Earnings for AMED:
Revenue 1.44B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.50 $0.53 $2.09 $2.40
Number of Analysts 5 5 5 5
High Estimate $0.56 $0.54 $2.14 $2.54
Low Estimate $0.48 $0.52 $2.05 $2.34
Prior Year $0.42 $0.36 $1.55 $2.09
Growth Rate (Year over Year) 19.52% 46.67% 34.84% 15.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
It's apparently not all doom and gloom in the private-equity realm of stock picking these days.
Feb 08, 2016 | 7:15 AM EST
AMED was upgraded from Perform to Outperform, Oppenheimer said. $40 price target. Stock has pulled back, but the outlook has improved u...
It's one of those things people are going to need regardless of the economy.
Jun 19, 2015 | 7:01 AM EDT
AMED was upgraded to Buy from Hold, Jefferies said. $48 price target. New management team brings renewed energy and direction that...
Jun 09, 2015 | 7:42 AM EDT
AMED was upgraded from Hold to Buy, Deutsche Bank said. $41 price target. New management can improve the company's growth profile. ...
A second look at three companies that provide end-of-life care.
Companies that provide end-of-life services have demographics on their side.
Sep 13, 2012 | 8:21 AM EDT
Shares of AMED now seen reaching $14, Jefferies said. Estimates also raised on improving admissions trends. Hold rating.
May 09, 2012 | 8:32 AM EDT
Shares of AMED now seen reaching $15, Jefferies said. Estimates also lowered on reimbursement uncertainty. Hold rating.

Columnist Conversations

Its been a rough year for GIS.  Heavy overhead pressure from the stock's 200 day moving average, which th...
Twitter (TWTR)  is back up to the 62% retracement level of its 2016 high and 2017 low. Above it is&n...
Sears (SHLD) announced they plan to start selling Kenmore appliances on Amazon (AMZN). SHLD shares are surging...
Today is going to be a great webinar after the close, with the BEST retail analyst on the planet.  Stacey...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.